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incorporated an informational component and
28.5% delineated sources, while 71.4% of Google
Play apps had an informational component, but
only 14.3% provided their sources. For operability,
57.1% of Apple apps had developer contact
information available, while all of the Google Play
apps did.
Conclusion: Most apps were functional and well
received by users, however quality of app content
varied. Only some apps had an informational
component, and even less had sources listed.
Providers recommending health apps should
consider those that meet Xcertia guidelines and
have reliable information.

Presented By: Moli Karsalia
Introduction: As technology becomes integrated
into healthcare, it becomes important to evaluate
mobile health applications (apps). We aim to
evaluate apps for Pelvic Organ Prolapse and
Stress Urinary Incontinence using Xcertia
guidelines for medical app quality and analyze app
usage.
Methods: Mobile medical apps were found on the
Apple App Store or Google Play Store with
keywords “pelvic organ prolapse,” “incontinence,”
or “bladder.” Exclusion criteria included 1) not free,
2) not updated in past year, 3) required a product
for use, 4) not in English. Apps were evaluated
along the Xcertia Guidelines. Categories included
Operability, Privacy, Security, Content, and
Usability. Ratings and sentiment of reviews were
assessed.
Results: On the Apple Store, 27 apps were found
and 7 were included. There was an average of
143.6 ratings, with an average score of 4.56.
Review sentiment analysis showed 4 apps with
majority positive sentiment, 1 with mostly negative
reviews, 1 with mostly neutral reviews, and 1 had
equal positive, negative, and neutral reviews. On
the Google Play Store, 46 apps were found and 21
were included. There was an average of 2968.8
ratings, with an average score of 4.21. Review
sentiment showed 11 apps with majority positive
sentiment, 3 with majority negative, 0 with majority
neutral, and 7 with equal reviews.
Based on Xcertia Guidelines, all apps met the
guidelines for privacy, security, and usability.
Regarding content, 57.1% of Apple apps
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Introduction: Previous studies have shown that
the fractional carbon dioxide (fCO2) vaginal laser
improves genitourinary symptoms of menopause.
It has been proposed that fCO2 vaginal laser can
also treat stress urinary incontinence (SUI) by
increasing collagen production. The aim of our

study was to evaluate the effect of vaginal fCO2
laser therapy in patient complaining of SUI.
Methods: Women over 18 years old with
complaints of urogenital symptoms who had been
off vaginal estrogen for at least three months were
enrolled in this open-label prospective trial.
Participants received 3 laser treatments
approximately 6 weeks apart. Stress test was
performed on patients at each visit. Responses to
the Incontinence-Quality of Life (I-QOL),
Questionnaire for Urinary Incontinence Diagnosis
(QUID), and Female Sexual Function Index (FSFI)
were collected at each treatment visit and at 6month follow-up. Responses to the Patient Global
Impression of Improvement (PGI-I) were collected
after the first treatment and then at every follow-up
visit. ANOVA analysis was used to compare
means at each time point.
Results: A total of 58 participants were enrolled.
Of these, 75.9% (44/58) complained of SUI.
Analysis was performed on the total of 30
participants who had undergone three treatments.
Sixty-three percent (19/30) were postmenopausal. Mean follow-up time was 7.7 (SD
3.7) months. Baseline stress test was positive in 6
of the 30 patients (20%). Stress test data was
available for 12 patients at the 6-month follow-up
and was positive in 2 patients (16.7%). No
difference was seen in total FSFI, I-QOL, or the
QUID-stress sub-score at the 6-month visit. There
was a trend towards improvement in the QUIDurge sub-score and the QUID-total (p = 0.06). The
mean PGI-I scores showed increased
improvement after each treatment and at 6months (p<0.01), Table 1.
Conclusion: Our preliminary results of this openlabel fCO2 vaginal laser show no objective or
subjective improvement in SUI after three
treatments. Sexual function symptoms also did not
significantly decrease after three treatments.
However, there was a trend towards improvement
in urge symptoms and patients did report global
improvement after each treatment. Further data
with larger numbers and longer follow-up are
needed to confirm these early findings.
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Introduction: Pessaries have recently resurfaced
as a viable non-surgical treatment option in recent
years in light of complications associated with
mesh used in the surgical treatment of SUI. While
the efficacy of pessaries in SUI has been studied,
few high-quality studies with large cohorts exist.
The purpose of this systematic review and metaanalysis is to synthesize existing evidence to
determine the sort-term efficacy of pessaries for
SUI using patient reported outcomes (PROs) and
objective measures.
Methods: This review was approved by the
PROSPERO database (CRD42020191677).
PubMed, EMBASE and CINAHL were searched
using the MeSH terms “stress urinary
incontinence” and “pessary, pessaries or
pessarium”. Studies were either randomized
control trials, prospective cohort studies,
prospective observational studies, retrospective
cohort studies that included PROs or objective
urodynamic data. Studies on pregnant women,
pediatric populations, women using pessaries for
indications other than SUI, and women using
electronic pessaries were excluded. The search
yielded 612 unique articles, of which 14 studies
were included in the analysis. Primary outcomes
were PROs, such as feeling continent, the
Urogenital Distress Inventory (UDI), and the
Incontinent Impact Questionnaire (IIQ). Secondary
outcomes included objective measures such as
the pad test, post-void residual (PVR), urethral
closure pressure, and pessary continuation rates.
Results: Participants were aged 51.4±4.1yr (n =
915, mean±SD) and primarily Caucasian (67%). At
baseline, parity was 2.1±0.5 (n=615), 46.36%
were postmenopausal (n=732), 8.04% had
undergone prior UI surgery was (n=734), and
25.34% had undergone prior nonsurgical UI
treatment (n=592). After pessary treatment, 76%
of women reported feeling continent (compared to
0% at baseline, n=154 at follow-up, p<0.0001).
Furthermore, UDI scores decreased by 44.3%
(n=160, p<0.0001), and IIQ scores decreased by
65.3% (n=118, p < 0.0001). At 1.5-6 months
follow-up, 78% of women continued to use the

